Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole-Heart Model of Short QT Syndrome.

Item

http://www.wikidata.org/entity/Q39694725

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@en

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@nl

type

Item

label

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@en

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@nl

prefLabel

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@en

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@nl

P1476

Ranolazine and Vernakalant Pre ...... rt Model of Short QT Syndrome.

@en

P2093

Christian Ellermann

http://www.w3.org/2001/XMLSchema#string

Christian Pott

http://www.w3.org/2001/XMLSchema#string

Dirk G Dechering

http://www.w3.org/2001/XMLSchema#string

Fatih Güner

http://www.w3.org/2001/XMLSchema#string

Patrick Leitz

http://www.w3.org/2001/XMLSchema#string

P2860

A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.

Sudden death associated with short-QT syndrome linked to mutations in HERG.

Electrophysiologic basis for the antiarrhythmic actions of ranolazine.

Atrial-selective sodium channel block strategy to suppress atrial fibrillation: ranolazine versus propafenone.

Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.

The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation.

Mechanisms underlying the development of the electrocardiographic and arrhythmic manifestations of early repolarization syndrome.

Primary prevention of sudden cardiac death in a nonischemic dilated cardiomyopathy population: reappraisal of the role of programmed ventricular stimulation.

P304

1214-1219

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JCE.13029

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27283775

http://www.w3.org/2001/XMLSchema#string